Showing results (3241-3250 of 37,639) with videos related to

Sort By:
Pageof 3,764
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Cancers|January 11, 2022
Combining Transarterial Radioembolization (TARE) and CT-Guided High-Dose-Rate Interstitial Brachytherapy (CT-HDRBT): A Retrospective Analysis of Advanced Primary and Secondary Liver Tumor TreatmentFlorian Nima Fleckenstein, Maximilian Julius Roesel, Maja Krajewska, et al.
Cancers|January 11, 2022
Targeting Estrogens and Various Estrogen-Related Receptors against Non-Small Cell Lung Cancers: A PerspectiveRadhashree Maitra, Parth Malik, Tapan Kumar Mukherjee
Cancers|January 11, 2022
Clinical Outcome Assessment in Cancer Rehabilitation and the Central Role of Patient-Reported OutcomesJens Lehmann, Maria Rothmund, David Riedl, et al.
Cancers|January 11, 2022
CANDIED: A Pan-Canadian Cohort of Immune Checkpoint Inhibitor-Induced Insulin-Dependent Diabetes MellitusThiago P Muniz, Daniel V Araujo, Kerry J Savage, et al.
Cancers|January 11, 2022
Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome InhibitionMahbuba R Subeha, Alicia A Goyeneche, Prisca Bustamante, et al.
Cancers|January 11, 2022
Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention RecommendationsShira Zelber-Sagi, Mazen Noureddin, Oren Shibolet
Cancers|January 11, 2022
Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based ImmunotherapyKoji Nagaoka, Changbo Sun, Yukari Kobayashi, et al.
Cancers|January 11, 2022
Radiotherapy in the Management of Non-Metastatic Inflammatory Breast Cancers: A Retrospective Observational StudyBenjamin Nicaise, Pierre Loap, Delphine Loirat, et al.
Cancers|January 11, 2022
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive MelanomaAnna M Czarnecka, Krzysztof Ostaszewski, Aneta Borkowska, et al.
Pageof 3,764